Could Pfizer and Merck Be Big Winners With COVID Pills?
19/9 13:55
Both Pfizer (NYSE: PFE) and Merck (NYSE: MRK) have recently announced they're advancing oral antiviral candidates targeting COVID-19 into late-stage testing. In this Motley Fool Live video recorded on Sept. 8, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss...